BC
Birchview Capital Portfolio holdings
AUM
$101M
This Quarter Return
-1.32%
1 Year Return
+34.62%
3 Year Return
+103.2%
5 Year Return
+107.72%
10 Year Return
+352.1%
AUM
$168M
AUM Growth
+$168M
(-3%)
Cap. Flow
+$2.1M
Cap. Flow
% of AUM
1.25%
Top 10 Holdings %
Top 10 Hldgs %
74.37%
Holding
57
New
9
Increased
8
Reduced
4
Closed
3
Top Buys
| 1 |
Cullinan Oncology
CGEM
|
$2.51M |
| 2 |
Acadia Pharmaceuticals
ACAD
|
$1.94M |
| 3 |
Nektar Therapeutics
NKTR
|
$1.84M |
| 4 |
Elicio Therapeutics
ELTX
|
$1.1M |
| 5 |
ALBO
Albireo Pharma, Inc. Common Stock
ALBO
|
$670K |
Top Sells
Sector Composition
| 1 | Healthcare | 96.34% |
| 2 | Energy | 1.49% |
| 3 | Consumer Staples | 0.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Bristol-Myers Squibb
BMY
$96B
| $50.1M | 29.76% |
794,186
-200
| -0% | -$12.6K |
|
2
Biodesix
BDSX
$62.6M
| $22.4M | 13.32% |
1,104,953
-130
| -0% | -$2.64K |
|
|
AXDX
3
DELISTED
Accelerate Diagnostics
AXDX
| $18.4M | 10.92% |
2,213,326
+19,531
| +0.9% | +$162K |
|
4
Neurocrine Biosciences
NBIX
$13.8B
| $7.8M | 4.63% |
80,200
| – | – |
|
5
QuidelOrtho
QDEL
$1.95B
| $7.5M | 4.45% |
58,644
| – | – |
|
|
6
Acadia Pharmaceuticals
ACAD
$4.38B
| $4.57M | 2.71% |
177,000
+75,000
| +74% | +$1.94M |
|
7
Foghorn Therapeutics
FHTX
$286M
| $4.14M | 2.46% |
314,143
| – | – |
|
|
ALBO
8
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
| $3.91M | 2.32% |
111,000
+19,000
| +21% | +$670K |
|
9
Biogen
BIIB
$19.4B
| $3.39M | 2.01% |
12,100
| – | – |
|
10
United Therapeutics
UTHR
$13.8B
| $3.01M | 1.79% |
18,000
| – | – |
|
|
XLRN
11
DELISTED
Acceleron Pharma Inc.
XLRN
| $2.53M | 1.5% |
18,672
| – | – |
|
|
12
Cullinan Oncology
CGEM
$445M
| $2.51M | 1.49% |
+60,114
| New | +$2.51M |
|
13
Karyopharm Therapeutics
KPTI
$61.7M
| $2.42M | 1.44% |
230,000
+42,000
| +22% | +$442K |
|
|
BLUE
14
DELISTED
bluebird bio
BLUE
| $2.28M | 1.35% |
75,500
+13,500
| +22% | +$407K |
|
|
AMRN
15
Amarin Corp
AMRN
$311M
| $1.86M | 1.11% |
300,000
| – | – |
|
|
16
Nektar Therapeutics
NKTR
$568M
| $1.84M | 1.09% |
+92,000
| New | +$1.84M |
|
17
Masimo
MASI
$7.59B
| $1.84M | 1.09% |
8,000
| – | – |
|
|
IMGN
18
DELISTED
Immunogen Inc
IMGN
| $1.54M | 0.91% |
190,000
| – | – |
|
|
CCXI
19
DELISTED
ChemoCentryx, Inc.
CCXI
| $1.54M | 0.91% |
30,000
| – | – |
|
|
ARNA
20
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $1.53M | 0.91% |
22,000
| – | – |
|
|
BIOR
21
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
| $1.29M | 0.76% |
270,000
+20,000
| +8% | +$95.2K |
|
22
Harrow
HROW
$1.44B
| $1.22M | 0.72% |
180,000
| – | – |
|
23
Vanda Pharmaceuticals
VNDA
$279M
| $1.2M | 0.71% |
80,000
| – | – |
|
24
Corcept Therapeutics
CORT
$7.35B
| $1.19M | 0.71% |
50,000
| – | – |
|
25
Soleno Therapeutics
SLNO
$3.6B
| $1.11M | 0.66% |
876,899
+50,000
| +6% | +$63K |
|